Amélie Boichard

Analysis of <i>NTRK</i> Alterations in Pan-Cancer Adult and Pediatric Malignancies: Implications for NTRK-Targeted Therapeutics

Ryosuke Okamura, Amélie Boichard, Shumei Kato et al. · JCO Precision Oncology · 2018 · 307 citations · Full text

Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy

Shumei Kato, Ki Hwan Kim, Hyo Jeong Lim et al. · Nature Communications · 2020 · 276 citations · Full text

Prevalence of<i>PDL1</i>Amplification and Preliminary Response to Immune Checkpoint Blockade in Solid Tumors

Aaron M. Goodman, David Piccioni, Shumei Kato et al. · JAMA Oncology · 2018 · 240 citations · Full text

Somatic<i>RAS</i>Mutations Occur in a Large Proportion of Sporadic<i>RET</i>-Negative Medullary Thyroid Carcinomas and Extend to a Previously Unidentified Exon

Amélie Boichard, L. Croux, Abir Al Ghuzlan et al. · The Journal of Clinical Endocrinology & Metabolism · 2012 · 149 citations · Full text

Circulating Cell-Free Tumor DNA Analysis of 50 Genes by Next-Generation Sequencing in the Prospective MOSCATO Trial

Cécile Jovelet, Ecaterina Ileana, Marie‐Cécile Le Deley et al. · Clinical Cancer Research · 2016 · 111 citations · Full text